Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We are in the middle of an opioid crisis in the US, with many lives lost daily to opioid-related deaths. Pharmacotherapy with methadone, buprenorphine, or naltrexone represents an important tool for clinicians during this crisis. But just how good are these medications in saving lives? A recent retrospective cohort study evaluated the effects of methadone, buprenorphine, and naltrexone on all-cause and opioid-related mortality in the 12 months after an opioid overdose.

Register For Free Articles

Register to receive free email newsletters with concise, practical advice for busy clinicians. You will also have access to select article content on the website and you will receive notifications of new books and special discount offers.

Dr. Arnaout is an assistant professor of psychiatry at the Yale School of Medicine. He completed medical school at the Jagiellonian University in Kraków, Poland; trained in psychiatry at St. Luke’s-Roosevelt Hospital Center in New York, where he also completed the Intensive Psychoanalytic Psychotherapy Program at the William Alanson White Institute of Psychiatry, Psychoanalysis & Psychology. He then trained in addiction psychiatry at the Yale School of Medicine. He has co-edited two books on addiction psychotherapy that draw on the theoretical framework of motivational interviewing: Handbook of Motivation and Change: A Practical Guide for Clinicians (American Psychiatric Publishing, Inc., 2010) and Motivational Interviewing in Clinical Practice (American Psychiatric Association Publishing, 2017).